Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.51% | 1.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.51% | 1.71% | |||
| Cost of Revenue | -9.88% | 1.35% | |||
| Gross Profit | 14.35% | 2.73% | |||
| SG&A Expenses | -13.42% | 9.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.16% | 4.05% | |||
| Operating Income | 59.64% | -21.83% | |||
| Income Before Tax | 94.90% | -50.67% | |||
| Income Tax Expenses | -263.16% | -10.38% | |||
| Earnings from Continuing Operations | 105.21% | -44.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 105.21% | -44.62% | |||
| EBIT | 59.64% | -21.83% | |||
| EBITDA | 60.71% | -22.51% | |||
| EPS Basic | 105.19% | -45.16% | |||
| Normalized Basic EPS | 94.94% | -51.92% | |||
| EPS Diluted | 105.00% | -50.54% | |||
| Normalized Diluted EPS | 94.94% | -51.92% | |||
| Average Basic Shares Outstanding | 0.04% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.04% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
